BTIG
Julian Harrison is currently a Director, Biotechnology Analyst at BTIG, covering a range of companies in the biotechnology sector. Previously, Julian held positions at Tekla Capital Management as a Senior Vice President and Senior Analyst focusing on healthcare investing. Julian also has experience as a Senior Vice President at BTIG and Vice President at H.C. Wainwright & Co., LLC. Julian holds a Master of Science degree in Health Economics and Policy from Joan & Sanford I. Weill Medical College of Cornell University, and a Bachelor of Science degree in Biology, Magna Cum Laude from Cornell University.
This person is not in any offices
BTIG
1 followers
BTIG is a global financial services firm specializing in investment banking, institutional trading, research and related brokerage services. With offices located throughout the U.S., Europe, Asia and Australia, our professionals leverage their expertise to service clients at every stage of the investment lifecycle. Fueled by our passion to help maximize results for our institutional and corporate clients, BTIG offers personalized multi-asset class execution, expertise and insights worldwide. The firm’s core capabilities include investment banking, global sales, portfolio, electronic and outsource trading, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. With a team of industry experts, BTIG provides end-to-end solutions for a diverse global client base. As we look to unlock value and propel growth for clients, we are consistently capturing market share year after year. Committed to excellence, we are proud of our rich history of designing solutions that help our clients achieve their objectives. For more information about BTIG, please visit www.btig.com. Member of FINRA and SIPC.